These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15762388)

  • 1. Neurobehavioral assessment of children and adolescents attending a developmental disabilities clinic.
    Brasić JR; Barnett JY; Kowalik S; Tsaltas MO; Ahmad R
    Psychol Rep; 2004 Dec; 95(3 Pt 2):1079-86. PubMed ID: 15762388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced movement disorders in institutionalised adults with mental retardation: clinical characteristics and risk factors.
    Sachdev P
    Aust N Z J Psychiatry; 1992 Jun; 26(2):242-8. PubMed ID: 1353672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Atypical antipsychotic use in treating adolescents and young adults with developmental disabilities.
    Bradley EA; Lunsky Y; Berg JM; Brooks-Hill RW; O'Leary DA; Harman KE; Korossy M
    Can J Psychiatry; 2002 Oct; 47(8):785; author reply 785-6. PubMed ID: 12420658
    [No Abstract]   [Full Text] [Related]  

  • 4. Akathisia in adults with mental retardation: development of the Akathisia Ratings of Movement Scale (ARMS).
    Bodfish JW; Newell KM; Sprague RL; Harper VN; Lewis MH
    Am J Ment Retard; 1997 Jan; 101(4):413-23. PubMed ID: 9017087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a test battery (NPM-X) for neuropsychological and neuromotor examination of children with developmental disabilities or mental retardation. A theoretical and clinical study.
    Gjaerum B
    Acta Psychiatr Scand Suppl; 1997; 390():1-55. PubMed ID: 9212855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
    Aman MG; Gharabawi GM;
    J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyskinesias subside off all medication in a boy with autistic disorder and severe mental retardation.
    Brasić JR; Barnett JY; Aisemberg P; Ahn SC; Nadrich RH; Kaplan D; Ahmad R; Mendonça Mde F
    Psychol Rep; 1997 Dec; 81(3 Pt 1):755-67. PubMed ID: 9400068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postural stability, tardive dyskinesia and developmental disability.
    Ko YG; Van Emmerik RE; Sprague RL; Newell KM
    J Intellect Disabil Res; 1992 Aug; 36 ( Pt 4)():309-23. PubMed ID: 1356038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic-related dyskinesias in children and adolescents.
    Connor DF; Fletcher KE; Wood JS
    J Clin Psychiatry; 2001 Dec; 62(12):967-74. PubMed ID: 11780878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of antipsychotics in children and adolescents.
    Findling RL; Steiner H; Weller EB
    J Clin Psychiatry; 2005; 66 Suppl 7():29-40. PubMed ID: 16124839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief report: risperidone for severely disturbed behavior and tardive dyskinesia in developmentally disabled adults.
    Khan BU
    J Autism Dev Disord; 1997 Aug; 27(4):479-89. PubMed ID: 9261670
    [No Abstract]   [Full Text] [Related]  

  • 12. Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents.
    Gualtieri CT; Quade D; Hicks RE; Mayo JP; Schroeder SR
    Am J Psychiatry; 1984 Jan; 141(1):20-3. PubMed ID: 6140865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tardive tremor.
    Stacy M; Jankovic J
    Mov Disord; 1992; 7(1):53-7. PubMed ID: 1348352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tardive dyskinesia in young mentally retarded individuals.
    Gualtieri CT; Schroeder SR; Hicks RE; Quade D
    Arch Gen Psychiatry; 1986 Apr; 43(4):335-40. PubMed ID: 2869741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case study: risperidone treatment of children and adolescents with developmental disorders.
    Hardan A; Johnson K; Johnson C; Hrecznyj B
    J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1551-6. PubMed ID: 8936923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyskinetic movement disorder among adults with mental retardation: phenomenology and co-occurrence with stereotypy.
    Bodfish JW; Newell KM; Sprague RL; Harper VN; Lewis MH
    Am J Ment Retard; 1996 Sep; 101(2):118-29. PubMed ID: 8883667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for tardive dyskinesia in adults with intellectual disability, comorbid psychopathology, and long-term psychotropic use.
    Matson JL; Fodstad JC; Neal D; Dempsey T; Rivet TT
    Res Dev Disabil; 2010; 31(1):108-16. PubMed ID: 19720497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Akathisia in neuroleptic medicated mentally handicapped subjects.
    Ganesh S; Murti Rao JM; Cowie VA
    J Ment Defic Res; 1989 Aug; 33 ( Pt 4)():323-9. PubMed ID: 2570159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotyped hand clasping: an unusual tardive movement disorder.
    Kaneko K; Yuasa T; Miyatake T; Tsuji S
    Mov Disord; 1993 Apr; 8(2):230-1. PubMed ID: 8474498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The problem of tardive akathisia.
    Gualtieri CT
    Brain Cogn; 1993 Sep; 23(1):102-9. PubMed ID: 8105819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.